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Background/Aims: The relationship between the appear-
ance of an ulcer and postoperative bleeding after gastric 
endoscopic submucosal dissection (ESD) is not well under-
stood. To explore this potential relationship, we retrospective-
ly analyzed the short-term healing process of ESD. Methods: 
A total of 520 consecutive lesions in 434 patients seen be-
tween January 2004 and December 2009 were retrospec-
tively investigated. At the second-look endoscopy, which oc-
curred between 1 and 8 days after ESD, artiﬁ  cial ulcers were 
categorized into 6 patterns according to Forrest’s classiﬁ  ca-
tion: spurting bleeding, oozing bleeding, non-bleeding visible 
vessel, adherent clot, black base/spot, and clean base. From 
these data, a short-term healing model of the artiﬁ  cial ulcer 
was generated. Results: Ulcer base changed gradually from   
a bloody to a clean one. The bleeding or non-bleeding visible 
vessel categories, which occurred in approximately one quar-
ter of the ulcers within 3 days of ESD, were rarely observed 4 
days after ESD. Conclusions: Ulcers that occur after gastric 
ESD heal in line with a speciﬁ  c time course, and it appears 
that most healing occurs without massive bleeding. (Gut 
Liver 2011;5:293-297)
Key Words: Endoscopic submucosal dissection; Artiﬁ  cial ul-
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INTRODUCTION
Endoscopic submucosal dissection (ESD) has been established 
as an alternative method to open surgery for a node-negative 
early gastric cancer, especially in Japan.
1-3 It is characterized by 
circumferential mucosal incision and submucosal dissection, 
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which enables en bloc resection even for large or ulcerative le-
sions. 
One of major complications is postoperative bleeding, which 
generally occurred in approximately 5% of the patients.
4-6 Vari-
ous countermeasures are empirically taken in order to prevent 
it, e.g., the use of proton pump inhibitor (PPI) around ESD, 
postendoscopic coagulation for visible vessels on a mucosal 
defect immediately after the resection of a lesion, a second-look 
endoscopy after ESD. PPI is thought to be effective from several 
studies including prospective randomized trials,
7,8 and its useful-
ness is generally gained acceptance in most hospitals, although 
there is still room for discussion about the suitable dose or dura-
tion. Postendoscopic coagulation immediately after the resection 
of the lesion also seems to be practiced in most hospitals and 
one retrospective analysis advocates the efficacy in post-ESD 
bleeding.
5 The usefulness of a second-look endoscopy, however, 
is controversial because few analyses exist.
6 Referring to bleed-
ing peptic ulcers, it is generally thought that a second-look 
endoscopy performed a few days after stopping initial bleeding 
may be useful especially for high-risk patients of rebleeding.
9-12 
But, the thought that it was equally useful for an artificial ulcer 
as well as for a bleeding peptic ulcer may be not always ap-
plicable, because the information about the artificial ulcer is too 
little to evaluate its efficacy satisfactory. We, therefore, retro-
spectively investigated the time-sequence changes of it checked 
by the second-look endoscopy after ESD. 
MATERIALS AND METHODS
Of 551 lesions in 457 patients treated by ESD after obtaining 
written informed consent in our hospital from January 2004 to 
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regarded as established at our hospital), consecutive 520 lesions 
in 434 patients were retrospectively investigated. Excluded were 
10 lesions in which perforation occurred after change of PPI 
due to the patient’s condition, 14 lesions without second-look 
endoscopy, and 7 lesions with bleeding that occurred within 24 
hours after ESD because those lesions less contributed to the 
elucidation of the natural course of artificial ulcers.
The indication of ESD were determined according to the 
endoscopic findings including chromoendoscopy with indigo 
carmine and biopsy, referring to the criteria of possible node-
negative early gastric cancer by Gotoda et al.
13 as followed: 1) 
intramucosal intestinal-type cancer without ulcerative find-
ings, regardless in size; 2) intramucosal intestinal-type cancer 
with ulcerative findings, 3 cm or less in size; 3) slight invasive 
intestinal-type cancer into submucosa less than 500 μm from 
muscularis mucosa, 3 cm or less in size; and 4) intramucosal 
diffuse-type cancer without ulcer findings, 2 cm or less in size. 
In addition, 5) adenoma difficult to distinguish from cancer or 
6) technically resectable cancer endoscopically out of the above 
criteria for which the patients strongly desired to be resected 
were indicated for ESD. Clinicopathological features of the eli-
gible lesions are shown in Table 1.
ESD techniques were precisely described elsewhere.
1-3 In brief, 
a flex-knife (KD-630L; Olympus, Tokyo, Japan) was used as the 
main electrosurgical knife for mucosal cutting of surrounding 
non-neoplastic mucosa and for submucosal dissection beneath 
the lesion.
2 A mixture of 10% glycerin plus 5% fructose and 0.9% 
saline preparation (Glyceol; Chugai Pharmaceutical Co., Tokyo, 
Japan) or hyaluronic acid was injected into submucosa under 
the lesion to make submucosal fluid cushion.
14,15 Hemostatic 
forceps (HDB2422W; Pentax, Tokyo, Japan) or hemostatic clips 
(HX-610-135 or HX-610-090L; Olympus) were used to stop 
bleeding or to cauterize visible vessels on the mucosal defect. 
If the patient’s symptoms, laboratory findings, and chest and 
abdominal X-rays were unremarkable at the next day of ESD, a 
light meal was permitted and the patients were discharged with-
in one week. From the day before ESD to at least 2 weeks after 
ESD, 10 mg of rabeprazole, 20 mg of omeprazole, or 30 mg of 
lansoprazole once daily was administered orally. Occasionally, 
20 mg of intravenous omeprazole twice daily was administered 
during the fasting period including the day of ESD, according to 
the decision of doctors in charge. 
A second-look endoscopy was performed to check bleeding or 
non-bleeding visible vessel on the artificial ulcer once between 
the day and 8 days after ESD. The day of second-look endos-
copy was irregularly decided taking into account the day of the 
week when ESD was performed and the operator’s convenience. 
If bleeding occurred or non-bleeding visible vessel was detected, 
(prophylactic) thermocoagulation with hemostatic forceps or 
mechanical hemostasis with hemostatic clips was executed. The 
way of hemostasis was flexibly selected according to the condi-
tion of bleeding. The treatment of (prophylactic) hemostasis was 
continued until active bleeding was stopped for several seconds 
even after flushing water or visible vessels apparently disap-
peared. 
In case of tightly adherent clot, presence of an apparent 
visible vessel beneath the clot was checked by removing it. If 
complications occurred, the schedules were changed according 
to the individual patient’s conditions. The patient was seen as 
an outpatient 2 weeks after discharge, and was checked by a 
follow-up endoscopy 2 months after ESD. Postoperative bleed-
ing was defined as bleeding or non-bleeding visible vessel with 
massively accumulated blood in the stomach on emergency en-
doscopy performed due to hematemesis or melena, or progres-
sion of anemia with vital changes. 
We investigated the artificial ulcers on the second-look en-
doscopy and categorized these ulcers into 6 patterns according 
to Forrest’s classification.
16,17 These ulcers were allocated into; 
spurting bleeding, oozing bleeding, non-bleeding visible ves-
sel, adherent clot, black base/spot, and clean base. The ulcers 
which caused postoperative bleeding confirmed by emergency 
endoscopy were allocated into spurting bleeding, regardless of 
active bleeding during endoscopy. Based on the allocation, the 
proportion of those patterns on each postoperative day was 
investigated to elucidate the natural healing process on the ar-
tificial ulcer’s surface. Subsequently, the bleeding rates after the 
second-look endoscopy according to these patterns of the ulcer 
were investigated. 
Table 1. Characteristics of the Enrolled Cases
Characteristic No. (Total 520 lesions)
Patient-related
Age, mean±SD, yr  68.5±9.1
Sex, M:F 396:124
Comorbidities (present:absent)
  Hypertension 116:404
  Diabetes mellitus 49:471
  Heart disease 44:476
  Chronic renal failure 8:512
  Liver cirrhosis 20:500
Anticoagulants/platelets (used:not used) 66:454
Lesion-related
Location (U or R:M:L) 118:182:220
Circumference (AW:GC:LC:PW) 97:90:196:137
Gross type (I/IIa:IIb/IIc:combined) 193:292:35
Ulcerative findings (present:absent) 57:463
Tumor size, mean±SD, mm  19.0±13.9
Tumor depth (mucosa:submucosa) 428:92
Histological type (carcinoma:adenoma) 447:73
SD, standard deviation; U, upper third; R, remnant stomach; M, 
middle third; L, lower third; AW, anterior wall; GC, greater curve; LC, 
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Statistical analysis was performed by chi-square test for cat-
egorical variables and p-value of less than 5% was considered 
significant. JMP version 8.0 software (SAS Institute, Cary, NC, 
USA) was used for all analyses. 
RESULTS
The patterns of the artificial ulcer after ESD related to the 
postoperative day were showed in Table 2. The second-look 
endoscopy was performed most on the postoperative day 1 (183 
lesions), and secondly on the postoperative day 6 (100 lesions). 
The numbers of the second-look endoscopies contained the 
emergency endoscopy performed due to possible postoperative 
bleeding. 
The proportion of the patterns on each postoperative day 
was showed in Fig. 1. As a natural course, the ulcer seemed to 
change gradually from bloody to clean base. Active bleeding or 
non-bleeding visible vessel, which was intended for endoscopic 
hemostatic treatment, appeared on approximately a quarter of 
the ulcers within 3 days after ESD, but were rarely observed 4 
days after ESD or later. 
Bleeding after the second-look endoscopy occurred in 12 le-
sions. The relationship between the findings on the second-look 
endoscopy and bleeding after that showed in Table 3. There was 
no apparent tendency for bleeding after the second-look endos-
copy among the patterns of the ulcers. 
DISCUSSION
In the present analysis, we demonstrated the model of short-
term healing process on the artificial ulcer after gastric ESD, 
owing to perform the second-look endoscopy once after ESD 
without any strict criteria. The previous studies have demon-
strated that the artificial ulcer usually heals within 2 months 
from active stage to scarring stage,
18 but this is the first report 
about the information of it during short interval of active stage. 
As Fig. 1 showed, the ulcer gradually changed from bloody ap-
pearance to clean surface covered with mucoid cap. The reason 
why the proportion of bloody patterns has made a dip on post-
Fig. 1. Proportion of the 6 artificial ulcer patterns according to post-
operative day. Over time, the number of ulcers with a bloody appear-
ance decreases, and a greater number are observed to have a clean 
base.
Table 2. Patterns of Artificial Ulcers after Endoscopic Submucosal Dissection according to Postoperative Day
Postoperative day
12345678
Spurting bleeding* 5 (2.7) 1 (3.7) 3 (5.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.3) 0 (0.0)
Oozing bleeding 15 (8.2) 0 (0.0) 4 (7.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Non-bleeding visible vessel 24 (13.1) 1 (3.7) 5 (9.3) 0 (0.0) 0 (0.0) 2 (2.0) 1 (1.3) 0 (0.0)
Adrehent clot 45 (24.6) 6 (22.2) 4 (7.4) 0 (0.0) 2 (14.3) 5 (5.0) 6 (7.5) 0 (0.0)
Black base/spot 69 (37.2) 15 (55.6) 21 (38.9) 18 (72.0) 5 (35.7) 51 (51.0) 35 (43.8) 8 (21.6)
Clean base 25 (14.2) 4 (14.8) 17 (31.5) 7 (28.0) 7 (50.0) 42 (42.0) 37 (46.3) 29 (78.4)
Total 183 (100) 27 (100) 54 (100) 25 (100) 14 (100) 100 (100) 80 (100) 37 (100)
Data are presented as number (%).
*These numbers contained the emergency endoscopy performed due to postoperative bleeding.
Table 3. Bleeding Rate after the Second-Look Endoscopy for Each 
Artificial Ulcer Pattern
Bleeding after the second-look 
endoscopy
No.
(12/520)
% 95% CI
The appearance of the artificial ulcer
Spurting bleeding* 0/10 0.0     0-27.8
Oozing bleeding* 0/19 0.0     0-16.8
Non-bleeding visible vessel* 1/33 3.0  0.5-15.3
Adherent clot
̈ 0/68 0.0     0-5.4
Black base/spot
̈   8/222 3.6  1.8-7.0
Clean base
̈   3/168 1.8  0.6-5.1
CI, confidence interval.
*Endoscopic intervention was performed; 
̈Endoscopic intervention 
was principally not performed.296  Gut and Liver, Vol. 5, No. 3, September 2011
operative day 4 is thought that the number of the second-look 
endoscopy performed on that day has been fewer compared 
to the other days. Fig. 1 implies that the second-look endos-
copy should be performed relatively soon after ESD (if it was 
expected to be worth to be done). Although the second-look 
endoscopy late after ESD (and almost before discharge) may be 
reasonable to check the possible bleeding spot, more effective 
timing of it is thought to be within 3 days after ESD, because 
the second-look endoscopy soon after ESD can frequently meet 
the targets for endoscopic intervention, whereas those rarely ex-
ist on it late after ESD. 
From the other side of view, Fig. 1 reflects the natural heal-
ing process of a single artificial ulcer. If clinically apparent 
postoperative bleeding such as spurting bleeding does not oc-
cur, the ulcer can be expected to heal without massive bleeding 
to some extent, even though oozing bleeding has occurred or 
non-bleeding visible vessel exists. That is, the figure implies 
that oozing bleeding may stop spontaneously, or non-bleeding 
visible vessel may disappear. For example, we can imagine that 
217 lesions checked on the postoperative day from 6 to 8 have 
almost improved spontaneously without clinically-problematic 
bleeding, in spite of the possibility that approximately a quarter 
of those may has had oozing bleeding or non-bleeding visible 
vessel. Hemostasis for oozing bleeding or prophylactic homo-
stasis for non-bleeding visible vessel may be certainly effective 
against further bleeding, but it may merely provide subclinical 
benefit. Many previous studies about bleeding peptic ulcer sug-
gest that active bleeding and non-bleeding visible vessel should 
be indicated for endoscopic intervention because these have 
high potential of rebleeding,
9-12,17 and that is why we empirically 
performed the second-look endoscopy after ESD. But, the suit-
able treatment to a bleeding peptic ulcer cannot be applicable 
to the artificial ulcer because both ulcers are quite different in 
many features, e.g., the cause of genesis, the circumstance in 
the stomach, and the depth. In that point, we need to construct 
another new strategy of caring for the artificial ulcer, and it will 
become relatively looser than that for a peptic ulcer. 
There is still room for discussion about the clinical efficacy of 
the second-look endoscopy. Fig. 1 speculates that almost all the 
artificial ulcers after ESD heal without massive bleeding. But, we 
cannot discuss about the necessity of the second-look endosco-
py after ESD only from this retrospective study. Another method 
to explain necessity of second-look endoscopy after ESD will 
be needed. A prospective study with more delicate groups, fixed 
time of second-look endoscopy, and patient’s clinical details is 
desired. 
On the other side, advanced endoscopic tool and new thera-
peutic strategy for hemostasis may be invented in the future, 
which will help to prevent postoperative bleeding after ESD 
more effectively. These advancements may also decrease neces-
sity of second-look endoscopy. 
The limitation is that this study is formed by a single-cen-
tered, retrospective analysis, although this is consecutive data. 
Besides, the change of the appearance on the artificial ulcer 
which we have showed is not an accumulation of data from 
longitudinal observation of a single ulcer, but from each one 
finding of many, various ulcers. In that point, the healing pro-
cess in Fig. 1 is still an assumption. Longitudinal observations 
of the single ulcer are ideal, but it would impossible either clini-
cally or ethically. 
 In conclusion, we could suggest the model of the short-term 
healing process on the artificial ulcer after gastric ESD from the 
findings of the second-look endoscopy. The ulcer changes from 
bloody to clean surface in line, and most of the ulcers are ex-
pected to heal without massive bleeding. 
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was 
reported.
REFERENCES
1. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection 
for treatment of early gastric cancer. Gut 2001;48:225-229. 
2. Yahagi N, Fujishiro M, Kakushima N, et al. Merits and demerits 
of endoscopic submucosal dissection using a flex-knife. Stomach 
Intest 2004;39:39-43.
3. Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dis-
section of early esophageal cancer. Clin Gastroenterol Hepatol 
2005;3(7 Suppl 1):S67-S70. 
4. Oka S, Tanaka S, Kaneko I, et al. Advantage of endoscopic sub-
mucosal dissection compared with EMR for early gastric cancer. 
Gastrointest Endosc 2006;64:877-883. 
5. Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible 
vessels may prevent delayed bleeding after endoscopic submucosal 
dissection--an analysis of risk factors. Endoscopy 2008;40:179-
183. 
6. Goto O, Fujishiro M, Kodashima S, et al. A second-look endos-
copy after endoscopic submucosal dissection for gastric epithelial 
neoplasm may be unnecessary: a retrospective analysis of posten-
doscopic submucosal dissection bleeding. Gastrointest Endosc 
2010;71:241-248. 
7. Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump 
inhibitor or an H2-receptor antagonist on prevention of bleeding 
from ulcer after endoscopic submucosal dissection of early gastric 
cancer: a prospective randomized controlled trial. Am J Gastroen-
terol 2007;102:1610-1616. 
8. Jeong HK, Park CH, Jun CH, et al. A prospective randomized trial 
of either famotidine or pantoprazole for the prevention of bleed-
ing after endoscopic submucosal dissection. J Korean Med Sci 
2007;22:1055-1059. 
9. Marmo R, Rotondano G, Bianco MA, Piscopo R, Prisco A, Cipol-
letta L. Outcome of endoscopic treatment for peptic ulcer bleeding: Goto O, et al: Short-Term Healing Process of Post-ESD Gastric Ulcers  297
is a second look necessary? A meta-analysis. Gastrointest Endosc 
2003;57:62-67. 
10.  Romagnuolo J. Routine second look endoscopy: ineffective, costly 
and potentially misleading. Can J Gastroenterol 2004;18:401-404. 
11.  Adamsen S, Bendix J, Kallehave F, Moesgaard F, Nilsson T, Wille-
Jørgensen P. Clinical practice and evidence in endoscopic treat-
ment of bleeding peptic gastroduodenal ulcer. Scand J Gastroen-
terol 2007;42:318-323. 
12.  Chiu PW, Lam CY, Lee SW, et al. Effect of scheduled second 
therapeutic endoscopy on peptic ulcer rebleeding: a prospective 
randomised trial. Gut 2003;52:1403-1407. 
13.  Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph 
node metastasis from early gastric cancer: estimation with a large 
number of cases at two large centers. Gastric Cancer 2000;3:219-
225. 
14.  Fujishiro M, Yahagi N, Kashimura K, et al. Comparison of various 
submucosal injection solutions for maintaining mucosal elevation 
during endoscopic mucosal resection. Endoscopy 2004;36:579-
583. 
15.  Fujishiro M, Yahagi N, Nakamura M, et al. Successful outcomes of 
a novel endoscopic treatment for GI tumors: endoscopic submuco-
sal dissection with a mixture of high-molecular-weight hyaluronic 
acid, glycerin, and sugar. Gastrointest Endosc 2006;63:243-249. 
16. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastroin-
testinal bleeding. Lancet 1974;2:394-397. 
17.  Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 
1994;331:717-727. 
18.  Kakushima N, Yahagi N, Fujishiro M, et al. The healing process of 
gastric artificial ulcers after endoscopic submucosal dissection. Dig 
Endosc 2004;16:327-331.